BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $294,405 | -99.8% | 13,706 | 0.0% | 0.00% | – |
| Q3 2022 | $162,005,000 | -10.5% | 13,706 | 0.0% | 0.00% | – |
| Q2 2022 | $180,919,000 | -36.9% | 13,706 | 0.0% | 0.00% | – |
| Q1 2022 | $286,592,000 | +2.9% | 13,706 | 0.0% | 0.00% | – |
| Q4 2021 | $278,643,000 | -57.3% | 13,706 | -36.3% | 0.00% | – |
| Q3 2021 | $652,950,000 | +9.0% | 21,514 | +4.4% | 0.00% | – |
| Q2 2021 | $598,869,000 | -16.4% | 20,608 | +24.1% | 0.00% | – |
| Q1 2021 | $716,456,000 | +19.3% | 16,600 | +27.7% | 0.00% | – |
| Q4 2020 | $600,600,000 | -5.1% | 13,000 | -11.0% | 0.00% | – |
| Q3 2020 | $633,056,000 | +125.3% | 14,600 | +175.5% | 0.00% | – |
| Q2 2020 | $280,953,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |